Upcoming FDA decision · November 10, 2026
Preservative-free Ketamine PDUFA date: FDA decision expected November 10, 2026
25 days to goNRX Pharmaceuticals, Inc. (NRXP) →
The FDA is expected to decide on Preservative-free Ketamine from NRX Pharmaceuticals, Inc. by the PDUFA target action date of November 10, 2026. ANDA filing. Extracted from SEC filing: EXHIBIT 99.1
A PDUFA date is the FDA's target deadline to complete its review of a drug application — approval, a complete response letter (CRL), or an extension are all possible. What is a PDUFA date? This page is research information, not financial advice.
Source: sec.gov · Data checked October 16, 2026. Confirm dates against the company's or the FDA's announcement before acting.
November 10
Target action date
NDA
Stage
Verified
Date confidence
—
FDA designations
Questions about this FDA decision
- When is the PDUFA date for Preservative-free Ketamine?
- The FDA's PDUFA target action date for Preservative-free Ketamine is November 10, 2026. The FDA can act before that date, and the review can be extended.
- Which company is developing Preservative-free Ketamine?
- NRX Pharmaceuticals, Inc. (NRXP).
- What can happen on a PDUFA date?
- The FDA approves the application, issues a complete response letter (CRL) listing what must be fixed before approval, or extends the review (typically by three months after a major amendment).